TickerFactsScreenerDevelopers

NEOGENOMICS INC (NEO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$2.05M2011: $69.0K2012: -$492.0K2013: $2.23M2017: $18.04M2018: $44.79M2019: $23.37M2020: $1.46M2021: -$26.72M2022: -$65.99M2023: -$1.95M2024: $7.02M2025: $5.23M$5.23M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$5.23M-25.5%
2024$7.02M+459.6%
2023-$1.95M+97.0%
2022-$65.99M-147.0%
2021-$26.72M-1930.3%
2020$1.46M-93.8%
2019$23.37M-47.8%
2018$44.79M+148.3%
2017$18.04M—
2013$2.23M+552.6%
2012-$492.0K-813.0%
2011$69.0K+103.4%
2010-$2.05M—